www.fdanews.com/articles/85242-zonagen-reports-fourth-quarter-and-year-end-2005-financial-results
ZONAGEN REPORTS FOURTH QUARTER AND YEAR END 2005 FINANCIAL RESULTS
March 13, 2006
Zonagen, Inc. today announced financial results for the year and fourth quarter ended December
31, 2005 and provided an update on the Proellex clinical program.
Total revenues
for 2005 were $634,000 as compared to $257,000 for 2004. Research and development
grants for 2005 were $4,000 as compared to $118,000 for 2004 relating to the Company's
Small Business Innovative Research ("SBIR") grants.
Black
Enterprise